Work

A 14-year retrospective of HER2 + metastatic breast cancer treatment at one comprehensive cancer center: Impact of the trastuzumab/pertuzumab and trastuzumab-emtansine sequence versus trastuzumab on overall survival

Year: 2024

Type: article

Study design: Observational Study

Source: Journal of Oncology Pharmacy Practice

DOI: 10.1177/10781552241289923

Authors: V Lepage, J Clarenne, B Fulbert, F Slimano, C Jouannaud, D Parent

Institutions: Centre Hospitalier Universitaire de Reims, BioSpectroscopie Translationnelle, Université de Reims Champagne-Ardenne, Institut Jean Godinot

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403403366

FWCI:

Cites: 5

Cited by:

Related to: 10